Comparison of balanced and unbalanced crystalloids as resuscitation fluid in patients treated for cardiogenic shock.

"Declarations Ethics approval and consent to participateThe study was approved by the local ethics committee of the Ludwig-Maximilians University Munich (IRB number: 18–001). Consent for publicationNot applicable. Competing interestsMartin Orban: Speaker honoraria from Abbott Medical, AstraZeneca, Abiomed, Bayer vital, BIOTRONIK, Bristol-Myers Squibb, CytoSorbents, Daiichi Sankyo Deutschland, Edwards Lifesciences Services, Sedana Medical, support for attending meetings from AstraZeneca, Stocks from Abbott Laboratories, Abbvie, AstraZeneca, Bayer, Biontech, Bristol-Meyer- Squibb, Curevac, Draegerwerk, Fresenius Medical Care, Gilead sciences, Inari Medical, Johnson&Johnson, Linde, Merck US, Moderna, NovoNordisk, Nuance Communications, Pfizer, Proctor&Gamble, Roche, SAP, Siemens healthiniers, Zoom. Jörg Hausleiter: Speaker honoraria from and serves as consultant for Abbott Vascular and Edwards Lifesciences. Clemens Scherer: Speaker honoraria from AstraZeneca. Ludwig Weckbach: Speaker honoraria from AstraZeneca and Bayer. Remaining authors: no conflicts of interest to declare. Competing interests Martin Orban: Speaker honoraria from Abbott Medical, AstraZeneca, Abiomed, Bayer vital, BIOTRONIK, Bristol-Myers Squibb, CytoSorbents, Daiichi Sankyo Deutschland, Edwards Lifesciences Services, Sedana Medical, support for attending meetings from AstraZeneca, Stocks from Abbott Laboratories, Abbvie, AstraZeneca, Bayer, Biontech, Bristol-Meyer- Squibb, Curevac, Draegerwerk, Fresenius Medical Care, Gilead sciences, Inari Medical, Johnson&Johnson, Linde, Merck US, Moderna, NovoNordisk, Nuance Communications, Pfizer, Proctor&Gamble, Roche, SAP, Siemens healthiniers, Zoom. Jörg Hausleiter: Speaker honoraria from and serves as consultant for Abbott Vascular and Edwards Lifesciences. Clemens Scherer: Speaker honoraria from AstraZeneca. Ludwig Weckbach: Speaker honoraria from AstraZeneca and Bayer. Remaining authors: no conflicts of interest to declare."

"Funding Open Access funding enabled and organized by Projekt DEAL."

"Trial registration : LMUshock registry (WHO International Clinical Trials Registry Platform Number DRKS00015860)."